Epibatidine application in vitro blocks retinal waves without silencing all retinal ganglion cell action potentials in developing retina of the mouse and ferret.
D000200:Action Potentials / Q000187:drug effects*; D000367:Age Factors; D000818:Animals; D000831:Animals, Newborn; D019086:Bridged Bicyclo Compounds, Heterocyclic / Q000494:pharmacology*; D005260:Female; D005289:Ferrets; D066298:In Vitro Techniques; D051379:Mice; D008810:Mice, Inbred C57BL; D018722:Nicotinic Agonists / Q000494:pharmacology*; D011247:Pregnancy; D011725:Pyridines / Q000494:pharmacology*; D012160:Retina / Q000166:cytology* / Q000254:growth & development*; D012165:Retinal Ganglion Cells / Q000145:classification / Q000187:drug effects* / Q000502:physiology; D013223:Statistics as Topic
D019086:Bridged Bicyclo Compounds, Heterocyclic; D018722:Nicotinic Agonists; D011725:Pyridines; C082748:epibatidine